Figure 1.
The cumulative incidence of CMV reactivation after HSCT from MUDs and MMRDs in patients with combined PIDs (n = 60) and other PIDs (n = 34).
The cumulative incidence of CMV reactivation after HSCT from MUDs and MMRDs in patients with combined PIDs (n = 60) and other PIDs (n = 34).